FINAPLIX-H- trenbolone acetate implant

Riik: Ameerika Ühendriigid

keel: inglise

Allikas: NLM (National Library of Medicine)

Toimeaine:

trenbolone acetate (UNII: RUD5Y4SV0S) (trenbolone - UNII:P53R4420TR)

Saadav alates:

Merck Sharp & Dohme Corp.

INN (Rahvusvaheline Nimetus):

trenbolone acetate

Koostis:

trenbolone 200 mg

Manustamisviis:

SUBCUTANEOUS

Retsepti tüüp:

OTC

Näidustused:

Increases rate of weight gain and improves feed efficiency in a slow-release delivery system. This product is to be used in feedlot heifers only during approximately the last 63 days prior to slaughter. Do not use in veal calves. Effectiveness and animal safety in veal calves have not been established.

Toote kokkuvõte:

Box of 10 × 10 cartridge implants.

Volitamisolek:

New Animal Drug Application

Toote omadused

FINAPLIX-H- TRENBOLONE ACETATE IMPLANT
MERCK SHARP & DOHME CORP.
----------
FINAPLIX -H
(TRENBOLONE ACETATE)
For Heifers
Fed In Confinement
For Slaughter
DESCRIPTION
Finaplix
-H (trenbolone acetate) is an implant containing 200 mg of trenbolone.
Each
implant consists of 10 small yellow pellets. Ten implants are provided
in a cartridge.
MANUFACTURED BY A NON-STERILIZING PROCESS.
INDICATIONS FOR USE
Increases rate of weight gain and improves feed efficiency in a
slow-release delivery
system. This product is to be used in feedlot heifers only during
approximately the last
63 days prior to slaughter.
Do not use in veal calves. Effectiveness and animal safety in veal
calves have not been
established.
DOSAGE
One implant containing 200 mg trenbolone acetate is administered to
each animal. The
10 pellets which make up the dosage of Finaplix
-H are contained in one division of the
multiple dose cartridge. Ten doses are in each cartridge. The
cartridge is designed to be
used with a special implant gun.
ROUTE OF ADMINISTRATION
The implant is placed under the skin on the posterior aspect of the
ear by means of a
special implanter available from Intervet Inc.
With the animal suitably restrained, the skin on the outer surface of
the ear should be
cleaned. The implant is then administered by the method shown in the
diagram below.
®
®
®
SITE OF IMPLANTATION
After appropriately restraining the animal to allow access to the ear,
cleanse the skin at
the implant needle puncture site. It is subcutaneous between the skin
and cartilage on
the back side of the ear and below the midline of the ear. The implant
must not be placed
closer to the head than the edge of the cartilage ring farthest from
the head. The
location of insertion of the needle is a point toward the tip of the
ear and at least a
needle length away from the intended deposition site. Care should be
taken to avoid
injuring the major blood vessels or cartilage of the ear.
METHOD OF USE
1. Do not remove the cap of the cartridge containing the implants.
2. Place the cartri